Global Computational Biology Market is segmented By Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software) By Tool (Databases, Infrastructure, Analysis Software and Services) By Service (In-House, Contract) By End User (Academic & Research, Industrial, Commercial, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Report Overview
Global Computational Biology market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
Computational biology is an exciting and quickly expanding field that blends the complexity of biological systems with the power of computers. It analyzes, interprets, and comprehends biological data, from genes and proteins to entire ecosystems, using computational and analytical approaches.
A computational biologist builds models to gain a deeper understanding of biological processes using biological data. uses massive data sets and computational and mathematical techniques to do analysis. It involves the representation and simulation of biological systems as well as the interpretation of experimental data, frequently on a very large scale, through the application of computer techniques.
Market Scope
|
Metrics |
Details |
|
CAGR |
YY% |
|
Market Size Available for Years |
2022-2031 |
|
Estimation Forecast Period |
2024-2031 |
|
Revenue Units |
Value (US$ Mn) |
|
Segments Covered |
Application, Tool, Service, End user |
|
Regions Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
|
Largest Region |
North America |
|
Fastest Growing Region |
Asia-Pacific |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report, – Request for Sample
Market Dynamics: Drivers & Restraints
Increase in research activities for drug discovery processes
The increase in research and developmental activities in drug discovery and at the molecular level is expected to drive market growth. The introduction of new databases and new software for drug discoveries and development is expected to drive market growth.
For instance, in October 2023, BioBam introduced OmicsBox 3.1, its latest version packed with innovative features designed to empower researchers, scientists, and bioinformaticians in their pursuit of advanced omics data analysis and interpretation.
Additionally, in January 2024, Uppaluri K&H Personalized Medicine Clinic unveiled GeneConnectRx, the diagnostic wing of the K&H clinic. It is expected that the discovery of a revolutionary step in personalized medicine will mark a paradigm shift, empowering healthcare providers to customize treatments based on individual genetic makeup. Thus, the above factors are expected to drive the market growth.
Lack of skilled resources to operate computational tools
Lack of professionals in the field is expected to hamper the market growth. It requires a unique blend of skills in biology, data science, computer science, and statistics to work in computational biology. Thus, finding experts with extreme knowledge can be difficult and is expected to hinder market growth.
Market Segment Analysis
The global computational biology market is segmented based on the application, tool, service, end user and region.
Cellular & Biological Simulation segment is expected to dominate the market share
The cellular and biological simulation segment is expected to hold the dominant position. The increase in research and development and the increase in investments and grant funds are expected to drive the segment growth and are expected to hold the segment in the dominant position in the forecast period.
For instance, in November 2022, Turbine Ltd., a U.K.-based cell behavior simulation company declared the closing of a US$ 20 million series financing round.
Additionally, in June 2022, Certara released new versions of its Immunogenicity (IG), Immuno-oncology (IO) and Vaccine Simulators to help predict how drugs work and address key questions in the development of novel biological therapies.
Market Geographical Analysis
North America is expected to hold a significant position in computational biology market share
North America has been dominant in the computational biology market share and is expected to continue throughout the forecast period. The research and development carried out in the region and also the investments and funding in the field have been holding the region in the dominant position.
For instance, in August 2023, the U.S. Department of Energy (DOE) declared $4.7 million in funding for five new research projects in computational biology. These projects will develop new software and analytical tools to manage the growing quantities of genomics and other data stemming from the study of microbes and other biological systems.
Additionally, in September 2023, it was stated that the NSF Science and Technology Center for Quantitative Cell Biology would be at the Beckman Institute for Advanced Science and Technology and supported by a $30 million U.S. National Science Foundation grant. Thus, the above factors are expected to hold the region in the dominant position in the forecast period.
COVID-19 Impact Analysis
COVID-19 has impacted the market growth. Closures and restrictions on laboratories affected ongoing research initiatives and data collection activities. This slowed down advancement in a number of fields, including the creation of vaccines and new drugs. Funding and resources were redirected to the pandemic response immediately, which would have slowed down research in other computational biology-related fields.
Market Competitive Landscape
The major global players in the market include Simulations Plus Inc., Insilico Biotechnology AG, Compugen Ltd., Certara., Nimbus Therapeutics., Athos Therapeutics, Thermo Fisher Scientific Inc., Schrödinger, Inc., Fios Genomics, Illumina, Inc. among others.
Why Purchase the Report?
- To visualize the global computational biology market segmentation based on the application, tool, service, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of the computational biology market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global computational biology market report would provide approximately 55 tables, 58 figures and 180 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
